USA - NASDAQ:VACC - US91864C1071 - ADR
ChartMill assigns a Buy % Consensus number of 82% to VACC. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-09-25 | Alliance Global Partners | Initiate | Buy |
| 2023-09-25 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2023-08-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-06-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-03-29 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-27 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-21 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-08-15 | Morgan Stanley | Maintains | Overweight |
| 2022-08-11 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-17 | Morgan Stanley | Maintains | Overweight |
| 2022-05-13 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-15 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-25 | William Blair | Initiate | Outperform |
| 2021-05-25 | Morgan Stanley | Initiate | Overweight |
| 2021-05-25 | Jefferies | Initiate | Buy |
| 2021-05-24 | HC Wainwright & Co. | Initiate | Buy |
11 analysts have analysed VACC and the average price target is 9.5 USD. This implies a price increase of 89.97% is expected in the next year compared to the current price of 5.
The consensus rating for VACCITECH PLC (VACC) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering VACCITECH PLC (VACC) is 11.